Literature DB >> 10516762

False human hematopoietic cell lines: cross-contaminations and misinterpretations.

H G Drexler1, W G Dirks, R A MacLeod.   

Abstract

The risk of adventitious contamination and subsequent overgrowth of cell lines by unrelated cells is a potential and often recurring problem where cells are grown and studied. This problem of intraspecies and interspecies cross-contamination among human cell lines has been recognized for over 25 years; incidences of cell cross-contamination between 17 and 35% have been reported. The most useful methods to detect human cell cross-contamination are DNA fingerprinting and cytogenetic analysis, each complementing the other. Using this combination, we found that in total 14.8% of the human hematopoietic cell lines received either from the original investigator (n = 117 cell lines) or from secondary sources (n = 72 cell lines) were cross-contaminated with another hematopoietic cell line and were thus false cell cultures. Another problem relates to the fact that not every cell line established from a patient with a hematopoietic malignancy is a malignant cell line; unintended immortalization of non-malignant B cells by 'passenger' Epstein-Barr virus (EBV) leads to the establishment of B-lymphoblastoid cell lines (termed EBV+ B-LCLs), an event which is much more frequent than the establishment of a 'true' leukemia-lymphoma-myeloma cell line. These EBV+B-LCLs are most often (albeit not always) unrelated to the malignant clone. The misinterpretation of such EBV+ B-LCLs as true malignant hematopoietic cell lines (particularly in research areas investigating B cell-derived neoplasms such as myeloma) and the indiscriminate use of these cell lines may render some of the results of such studies irrelevant to the pathobiology of the disease concerned. However, a combination of markers commonly allows for an accurate determination of the nature of EBV+ B-LCLs: immunoprofile, cellular morphology, EBV status, and karyotype. In summary, the continuous need for vigilant quality and identity control procedures is emphasized by the high incidences of cross-contaminated cell lines. Most laboratories using cells cultured in vitro maintain multiple cell lines. Such cell lines should be monitored regularly for their identity and specific characteristics in order to prevent invalidation of research work due to incidents of cell line cross-contamination or misinterpretation.

Entities:  

Mesh:

Year:  1999        PMID: 10516762     DOI: 10.1038/sj.leu.2401510

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  22 in total

1.  Utility of gender determination in cell line identity.

Authors:  A S Durkin; E Cedrone; G Sykes; D Boles; Y A Reid
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  A simple method using beta-globin polymerase chain reaction for the species identification of animal cell lines--a progress report.

Authors:  Klaus G Steube; Corinna Meyer; Cord C Uphoff; Hans G Drexler
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Nov-Dec       Impact factor: 2.416

3.  Bladder carcinoma cell line ECV304 is not a model system for endothelial cells.

Authors:  Hans G Drexler; Hilmar Quentmeier; Wilhelm G Dirks; Roderick A F MacLeod
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-04       Impact factor: 2.416

4.  Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.

Authors:  Kurt E J Dittmar; Meike Simann; Nadia Zghoul; Oliver Schön; Wilhelm Meyring; Horst Hannig; Lars Macke; Wilhelm G Dirks; Konstantin Miller; Henk S P Garritsen; Werner Lindenmaier
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

5.  False cell lines: The problem and a solution.

Authors:  John R Masters
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

6.  Looking Back from the Future to the Present: Biopreservation Will Get Us There!

Authors:  Andreas Sputtek; Arthur W Rowe
Journal:  Transfus Med Hemother       Date:  2011       Impact factor: 3.747

7.  DNA fingerprinting: a quality control case study for human biospecimen authentication.

Authors:  Olga A Kofanova; William Mathieson; Gerry A Thomas; Fotini Betsou
Journal:  Biopreserv Biobank       Date:  2014-02-14       Impact factor: 2.300

8.  Detection algorithm for the validation of human cell lines.

Authors:  Névine Eltonsy; Vivian Gabisi; Xuesong Li; K Blair Russe; Gordon B Mills; Katherine Stemke-Hale
Journal:  Int J Cancer       Date:  2012-04-12       Impact factor: 7.396

Review 9.  Persistent use of false myeloma cell lines.

Authors:  Hans G Drexler; Yoshinobu Matsuo; Roderick A E MacLeod
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

10.  Molecular detection of cell line cross-contaminations using amplified fragment length polymorphism DNA fingerprinting technology.

Authors:  E Milanesi; P Ajmone-Marsan; E Bignotti; M N Losio; J Bernardi; F Chegdani; M Soncini; M Ferrari
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.